Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$567.98 USD
+5.22 (0.93%)
Updated May 31, 2024 04:00 PM ET
After-Market: $568.45 +0.47 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Brokerage Reports
Thermo Fisher Scientific Inc. [TMO]
Reports for Purchase
Showing records 421 - 440 ( 545 total )
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Updating Estimates to Reflect Close of FEIC; PT Unchanged
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
No Major Surprises; Consistency in Execution Appreciated
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Relatively in Line Results/Guidance on a Busy Day of Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Remains One of Our Top Picks in Life Science Tools/Industrials; Raising PT to $167
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
TMO Appears the Most Logical Fit for FEIC Given Its Size and Overall Diversification
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Equity Research: Research Summary
Provider: KEYBANC CAPITAL MARKETS